Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

All news

Show

From To
PrEP: A Dream Deferred

PrEP is largely failing to help those who need an HIV prevention game changer most desperately, namely Black MSM, in particular those younger than 25.

Published
3 hours ago
From
Poz
Trump Team’s Queries About Africa Point to Skepticism About Aid

President-elect Donald J. Trump’s views of Africa have, until now, been a mystery. But a series of questions from the Trump transition team to the State Department indicate an overall skepticism about the value of foreign aid, and even about American security interests, on the world’s second-largest continent.

Published
4 hours ago
From
New York Times
ChemSex care plan

A new online, interactive resource to assist healthcare practitioners to guide ChemSex patients through a behaviour-change Care Plan, is now live. Designed for people who use chems who might be unable or unwilling to access support services, or for drugs workers/sexual health staff in areas where there are no ChemSex support services

Published
5 hours ago
From
David Stuart
The U.S. Government Should Buy Gilead For $156 Billion To Save Money On Hepatitis C

The U.S. government could cure most Americans suffering from hepatitis C infections if it simply bought drug maker Gilead Sciences on the stock market rather than purchasing its products in the drug market.

Published
5 hours ago
From
Forbes
SA can save billions with new HIV drug combination

The ADVANCE study will evaluate an HIV treatment regimen including two newer and cheaper drugs: dolutegravir (DTG) and tenofovir alafenamide (TAF).

Published
5 hours ago
From
Health24
DIY test for HIV comes to a pharmacy near you

For R59.95 South Africans can now purchase an HIV testing kit from a local pharmacy and screen themselves for infection in the privacy of their homes – effectively by-passing the health system altogether.

Published
5 hours ago
From
Health-e
HIV treatment might boost susceptibility to syphilis, say researchers

The antiretroviral drugs used to treat HIV infection might inadvertently be boosting gay/bisexual men's susceptibility to the bacteria responsible for syphilis, Treponema pallidum, conclude researchers in the journal Sexually Transmitted Infections.

Published
7 hours ago
From
Eurekalert Medicine & Health
Tenofovir alafenamide approved for hepatitis B in Europe

The European Commission this week granted marketing authorisation for tenofovir alafenamide, to be sold under the brand name Vemlidy, for the treatment of chronic hepatitis

Published
10 hours ago
By
Liz Highleyman
Converging Roads Between HIV and Cancer Research

In 2017, a key focus in the field of HIV will be investigating new ways to tackle persistence via interactions and synergies with other fields such as cancer research and immune-based therapies. This will take centre stage when the scientific community convenes in July 2017 at the IAS HIV Cure & Cancer Forum and the 9th IAS Conference on HIV Science (IAS 2017).

Published
16 January 2017
From
International AIDS Society
Zimbabwe: Zim to Roll Out Pre-Exposure HIV Pill

ZIMBABWE will soon start rolling out pre-exposure prophylaxis (PrEP) medication in selected districts in the country after adopting World Health Organisation (WHO) guidelines on HIV treatment and prevention.

Published
16 January 2017
From
AllAfrica
← First12345...2208Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.